Li Xiao

201 Hubin South Road
Xiamen, 361004, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Lentiviral Dendritic Cell Vaccine Targeting Claudin-18.2 Elicits Potent Antitumor Immunity Against Gastric Cancer.

Lentiviral Dendritic Cell Vaccine Targeting Claudin-18.2 Elicits Potent Antitumor Immunity Against Gastric Cancer.

Journal: Cancers
Published: December 05, 2025

Apatinib enhances anti-PD-1 efficacy by inhibiting Exo70-mediated exosome secretion in pMMR/MSS colorectal cancer.

Apatinib enhances anti-PD-1 efficacy by inhibiting Exo70-mediated exosome secretion in pMMR/MSS colorectal cancer.

Journal: NPJ precision oncology
Published: November 17, 2025

Claudin18.2 promote gastric cancer proliferation by activating MCM2/5.

Claudin18.2 promote gastric cancer proliferation by activating MCM2/5.

Journal: Scientific reports
Published: September 24, 2025

CDK4/6i reverse PARPi resistance by targeting the E2F1- MCM2/5 pathway.

CDK4/6i reverse PARPi resistance by targeting the E2F1- MCM2/5 pathway.

Journal: NPJ precision oncology
Published: August 25, 2025

Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy.

Efficacy of single low-dose dexamethasone with NEPA for the 168 h prevention of highly or moderately emetogenic chemotherapy.

Journal: Frontiers in pharmacology
Published: May 04, 2025

Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC).

Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC).

Journal: Cancers
Published: January 10, 2025

Apatinib Degrades PD-L1 and Reconstitutes Colon Cancer Microenvironment via the Regulation of Myoferlin.

Apatinib Degrades PD-L1 and Reconstitutes Colon Cancer Microenvironment via the Regulation of Myoferlin.

Journal: Cancers
Published: December 05, 2024

Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer.

Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer.

Journal: Clinical and translational medicine
Published: June 27, 2024

Full-length GSDME mediates pyroptosis independent from cleavage.

Full-length GSDME mediates pyroptosis independent from cleavage.

Journal: Nature cell biology
Published: December 21, 2023

Exo70 Promotes the Invasion of Pancreatic Cancer Cells via the Regulation of Exosomes.

Exo70 Promotes the Invasion of Pancreatic Cancer Cells via the Regulation of Exosomes.

Journal: Cancers
Published: December 04, 2023

Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway.

Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway.

Journal: Cancer cell international
Published: May 06, 2023

An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration.

An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration.

Journal: EMBO reports
Published: January 18, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026